HR 6807
KO Cancer Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The KO Cancer Act aims to significantly increase funding for cancer research at the National Cancer Institute (NCI). Specifically, it proposes to allocate 25% of the NCI’s 2022 budget to cancer research over the next seven years. Additionally, the bill directs the Department of Health and Human Services to investigate the causes of cancer drug shortages and provide recommendations to Congress for addressing these issues.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Abigail Davis Spanberger
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.